Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 10:47 am Purchase | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Solas Capital Management LLC | 1,378,513 5.2% | 1,378,513 (New Position) | View |
| 2023-02-14 3:35 pm Purchase | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic GP LLC | 2,578,134 9.8% | 2,578,134 (New Position) | View |
| 2022-02-14 09:08 am Sale | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic Fund II L.P. | 2,469,880 9.5% | -25,873 (-1.04%) | View |
| 2022-02-11 10:08 am Sale | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Avoro Capital Advisors LLC | 1,200,000 4.6% | -470,000 (-28.14%) | View |
| 2021-02-16 3:44 pm Purchase | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic Fund II L.P. | 2,495,753 9.7% | 2,495,753 (New Position) | View |
| 2021-02-12 4:00 pm Purchase | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Southpoint Capital Advisors LP | 4,077,214 15.8% | 80,000 (+2.00%) | View |
| 2021-02-12 08:01 am Purchase | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Avoro Capital Advisors LLC | 1,670,000 6.5% | 564,001 (+50.99%) | View |
| 2020-05-04 5:22 pm Purchase | 13D | FENNEC PHARMACEUTICALS, INC. O FENC | Essetifin SPA | 3,993,694 16.2% | 768,000 (+23.81%) | View |